Gold-Based Nanostructures for Antibacterial Application
Chinmaya Mutalik1, Muhammad Saukani2,3, Muhamad Khafid4
1Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan.
International Journal of Molecular Sciences
|June 28, 2023
Summary
Gold nanostructures show promise as antibacterial agents against drug-resistant bacteria. This review details various gold nanoparticle (AuNP) designs and their mechanisms for combating infections, offering future clinical perspectives.
Area of Science:
- Nanotechnology
- Materials Science
- Infectious Diseases
Background:
- Antibiotic resistance is a growing global health crisis.
- Gold (Au)-based nanostructures offer unique properties for combating bacterial infections.
- Diverse Au nanostructures have been investigated for their antibacterial potential.
Purpose of the Study:
- To review and summarize the current advancements in Au-based nanostructures as antibacterial agents.
- To discuss the rational design, antibacterial activities, and mechanisms of various Au nanostructures.
- To provide perspectives on the future clinical applications of Au-based antibacterial agents.
Main Methods:
- Literature review of Au-based nanostructures for antibacterial applications.
- Categorization of nanostructures by shape (nanoparticles, nanoclusters, nanorods, nanobipyramids, nanostars), size, and surface modification.
- Analysis of antibacterial mechanisms and efficacy.
Main Results:
- Various gold nanostructures (AuNPs, AuNCs, AuNRs, AuNBPs, AuNSs) exhibit significant antibacterial activity.
- Antibacterial efficacy is influenced by shape, size, and surface modifications.
- Mechanisms include oxidative stress, membrane damage, and interference with cellular processes.
Conclusions:
- Au-based nanostructures represent a promising alternative to conventional antibiotics.
- Further research into rational design and clinical translation is warranted.
- Challenges and opportunities exist for the practical application of these novel antibacterial agents.


